Premium
A survey of reimbursement for cystic fibrosis carrier testing
Author(s) -
Bernhardt Barbara A.
Publication year - 1993
Publication title -
journal of genetic counseling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 52
eISSN - 1573-3599
pISSN - 1059-7700
DOI - 10.1007/bf00962540
Subject(s) - reimbursement , medicine , public health , cystic fibrosis , human genetics , genetic counseling , family medicine , medical physics , pathology , genetics , biology , health care , political science , law , gene
To assess the current status of reimbursement for cystic fibrosis (CF) carrier testing, we surveyed individuals tested in the Mid‐Atlantic region. Results show that CF testing was covered by insurance in part or in full for greater than 50% of respondents. The test was nearly always covered when performed during pregnancy because of a positive family history, but it was also covered for more than 50% of pregnant respondents with a negative family history. There were no significant differences in coverage by type of insurance. Many respondents needed to supply additional information about the testing to their insurance company before a coverage decision could be made. Before population‐based CF screening programs are initiated, more data are needed on insurance reimbursement for testing, especially when performed pre‐conceptually .